Pharma Q2 Preview: Demonstrating Resiliency Against A Turbulent Backdrop

 
• By Jessica Merrill

Inflation, rising interest rates, market volatility, violence in Ukraine and a persistent pandemic created a chaotic macroenvironment for doing business. Pharma appears poised to grow, nonetheless.

second quarter
Pharma is poised to update investors on second quarter results • Source: Shutterstock

More from Strategy

More from Business